2023 Fall Clinical Virtual Grand Rounds
2023 Virtual Grand Rounds Session 10: September 6, 2023 - Case Conversations: Optimizing PDT In Your Practice One Patient at a Time
About
Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases and tools, delivered by the top experts in dermatology. Please join us for this week's session:
Wednesday, September 6, 2023
8 PM ET / 5 PM PT
Case Conversations: Optimizing PDT in Your Practice One Patient at a Time
This activity is supported by an educational grant from Biofrontera.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
September 7, 2023
September 7, 2024
Learning Objectives
At the completion of this activity, participants should be better able to:
Describe the key data on photodynamic therapy to manage actinic keratosis
Identify patients with actinic keratosis for photodynamic therapy
Discuss strategies to optimize care of patients with actinic keratosis with photodynamic therapy
Intended Audience
Faculty
Ashish Bhatia
Associate Professor of Clinical Dermatology
Northwestern University
Feinberg School of Medicine
Chicago, IL
Anthony Rossi, MD
Assistant Attending
Memorial Sloan Kettering Cancer Center
New York, NY
Linda Stein Gold, MD
Director Clinical Research
Henry Ford Health System
Detroit, MI
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Advisory Board/Consultant: Alastin Skincare, Allergan/AbbVie, Avita Medical, Bausch Health, Carpe, Cutera, Cytrellis, Emblation, Ltd., Entrepix Medical, Evolus Medline, MiMedx, Ortho Dermatologics, Revance, Solta, SofWave, Strata Skin Sciences, Theravant Corp
Board Member: Theravant Corporation, DermEd Foundation
Shareholder: Biomarck, Carpe, Cuera, DermMD, Ganzum, SimSkin, Sonoma, Theravant Corporation, Zalea
Grant/Research Supporter: Abbvie, Alastin Skincare, Avita Medical, Cutera, Medline, Novascan, Pulse Bioscienceds, R2 Technologies, Revance
Speaker's Bureau: Allergan, Cutera, DermEd Foundation, Evolus, Medline, MiMedx, Ortho Dermatologics, Paradigm, Revance, Theravant Corp.
Intellectual Property/Patents: BioMarck
Advisory Board: Allergan
Consultant: Almirall, Biofrontera, Evolus Mavig, Merz, Dynamed, Canfield Scientific, Allergan, Lam Therapeutics, Regeneron, Cutera, Skinfix
Employee/owner: DAR companies (Founder)
Grant/Research Support: Biofrontera, Regeneron, LEO,
Grant/Research Support: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie
Consultant: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie
Speakers’ Bureau or Honoraria: Leo, AbbVie, Almirall, Galderma, Pfizer, Sanofi, Regeneron
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.